版本:
中国

BRIEF-Axsome Therapeutics receives FDA fast track designation for axs-05 for alzheimer’s disease agitation

May 8 Axsome Therapeutics Inc

* Axsome therapeutics receives fda fast track designation for axs-05 for alzheimer’s disease agitation Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐